The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: Impact of gender

Annals of Epidemiology

Volumn 22, Issue 12, 2012, Pages 855-862

  Kelly, Jennifer L ^a   Fredericksen, Zachary S ^b   Liebow, Mark ^b   Shanafelt, Tait D ^b   Thompson, Carrie A ^b   Call, Timothy G ^b   Habermann, Thomas M ^b   Macon, William R ^b   Wang, Alice H ^b   Slager, Susan L ^b   Cerhan, James R ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Body mass index; Case control studies; Etiology; Exercise; Non Hodgkin lymphoma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; ODDS RATIO; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84870239683     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.10.002     Document Type: Article

References (56)

1. American Cancer Society Cancer facts and figures 2011 2011, American Cancer Society, Atlanta, GA.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
3. Alexander D.D., Mink P.J., Adami H.O., Chang E.T., Cole P., Mandel J.S., et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007, 120(Suppl. 12)):1-39.
4. Fisher S.G., Fisher R.I. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004, 23(38):6524-6534.
5. Grulich A.E., Vajdic C.M. The epidemiology of non-Hodgkin lymphoma. Pathology 2005, 37(6):409-419.
6. Grulich A.E., Vajdic C.M., Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007, 16(3):405-408.
7. Devesa S., Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992, 52(19):5432s-5440s.
8. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., Linet M.S. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006, 107(1):265-276.
9. Muller A.M., Ihorst G., Mertelsmann R., Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005, 84(1):1-12.
10. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295(13):1549-1555.
11. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497.
12. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303(3):235-241.
13. Centers for Disease Control and Prevention Prevalence of regular physical activity among adults-United States, 2001 and 2005. JAMA 2008, 299(1):30-32.
14. International Agency for Research on Cancer (IARC) Weight control and physical activity, Volume 6. IARC Handbooks of Cancer Prevention 2002, IARC Press, Lyon, France.
15. Wolin K.Y., Carson K., Colditz G.A. Obesity and cancer. Oncologist 2010, 15(6):556-565.
16. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17(11-12):953-966.
17. Roberts D.L., Dive C., Renehan A.G. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 2010, 61:301-316.
18. Marti A., Marcos A., Martinez J.A. Obesity and immune function relationships. Obes Rev 2001, 2(2):131-140.
19. Friedenreich C.M., Orenstein M.R. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002, 132(11 Suppl.):3456S-3464S.
20. Lichtman M.A. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist 2010, 15(10):1083-1101.
21. Larsson S.C., Wolk A. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer 2007, 121(7):1564-1570.
22. Bosetti C., Dal Maso L., Negri E., Talamini R., Montella M., Franceschi S., et al. Re: Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005, 97(11):860-861.
23. Kanda J., Matsuo K., Suzuki T., Hosono S., Ito H., Ichinohe T., et al. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer 2010, 126(10):2416-2425.
24. Skibola C.F., Holly E.A., Forrest M.S., Hubbard A., Bracci P.M., Skibola D.R., et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004, 13(5):779-786.
25. Kabat G.C., Kim M.Y., Jean Wactawski W., Bea J.W., Edlefsen K.L., Adams-Campbell L.L., et al. Anthropometric factors, physical activity, and risk of non-Hodgkin's lymphoma in the Women's Health Initiative. Cancer Epidemiol 2012, 36(1):52-59.
26. Troy J.D., Hartge P., Weissfeld J.L., Oken M.M., Colditz G.A., Mechanic L.E., et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 2010, 171(12):1270-1281.
27. Lu Y., Prescott J., Sullivan-Halley J., Henderson K.D., Ma H., Chang E.T., et al. Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am J Epidemiol 2009, 170(10):1231-1240.
28. Pylypchuk R.D., Schouten L.J., Goldbohm R.A., Schouten H.C., van den Brandt P.A. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol 2009, 170(3):297-307.
29. Maskarinec G., Erber E., Gill J., Cozen W., Kolonel L.N. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2008, 17(1):196-203.
30. Lim U., Morton L.M., Subar A.F., Baris D., Stolzenberg-Solomon R., Leitzmann M., et al. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007, 166(6):697-708.
31. Cerhan J.R., Janney C.A., Vachon C.M., Habermann T.M., Kay N.E., Potter J.D., et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002, 156(6):527-535.
32. Chiu B.C., Soni L., Gapstur S.M., Fought A.J., Evens A.M., Weisenburger D.D. Obesity and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2007, 18(6):677-685.
33. Cerhan J.R., Bernstein L., Severson R.K., Davis S., Colt J.S., Blair A., et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control 2005, 16(10):1203-1214.
34. Pan S.Y., Mao Y., Ugnat A.M. Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol 2005, 162(12):1162-1173.
35. van Veldhoven C.M., Khan A.E., Teucher B., Rohrmann S., Raaschou-Nielsen O., Tjonneland A., et al. Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC). Eur J Cancer 2011, 47(5):748-760.
36. Teras L.R., Gapstur S.M., Diver W.R., Birmann B.M., Patel A.V. Recreational physical activity, leisure sitting time and risk of non-Hodgkin lymphoid neoplasms in the American Cancer Society Cancer Prevention Study-II Cohort. Int J Cancer 2012, 131(8):1912-1920.
37. Cerhan J.R., Fredericksen Z.S., Wang A.H., Habermann T.M., Kay N.E., Macon W.R., et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet 2011, 2(2):95-113.
38. WHO Expert Committee on Physical Status Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee 1995, World Health Organization, Geneva, Switzerland.
39. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35(8):1381-1395.
40. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32(9 Suppl.):S498-S504.
41. Kelly J.L., Drake M.T., Fredericksen Z.S., Asmann Y.W., Liebow M., Shanafelt T.D., et al. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control 2012, 23(7):1017-1029.
42. Holtan S.G., O'Connor H.M., Fredericksen Z.S., Liebow M., Thompson C.A., Macon W.R., et al. Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma. Int J Cancer 2012, 131(5):1158-1168.
43. Rothman K.J., Greenland S. Modern epidemiology 1998, Lippincott Williams & Wilkins, Philadelphia, PA. 2nd edn.
44. Larsson S.C., Wolk A. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 2011, 47(16):2422-2430.
45. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371(9612):569-578.
46. Willett E.V., Morton L.M., Hartge P., Becker N., Bernstein L., Boffetta P., et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008, 122(9):2062-2070.
47. Willett E.V., Skibola C.F., Adamson P., Skibola D.R., Morgan G.J., Smith M.T., et al. Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 2005, 93(7):811-816.
48. Chang E.T., Hjalgrim H., Smedby K.E., Akerman M., Tani E., Johnsen H.E., et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005, 97(3):210-218.
49. Poole E.M., Tworoger S.S., Hankinson S.E., Schernhammer E.S., Pollak M.N., Baer H.J. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol 2011, 174(6):642-651.
50. Maruotti N., Cantatore F.P. Vitamin d and the immune system. J Rheumatol 2010, 37(3):491-495.
51. Ogden C.L., Flegal K.M., Carroll M.D., Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002, 288(14):1728-1732.
52. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Muller J., et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997, 82(9):2904-2910.
53. Fisher R.I. Overview of non-Hodgkin's lymphoma: biology, staging, and treatment. Semin Oncol 2003, 30(2 Suppl. 4):3-9.
54. Morton L.M., Wang S.S., Cozen W., Linet M.S., Chatterjee N., Davis S., et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008, 112(13):5150-5160.
55. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004, 4(8):579-591.
56. Pischon T., Nothlings U., Boeing H. Obesity and cancer. Proc Nutr Soc 2008, 67(2):128-145.